E. LaVoie

E. LaVoie, S. Sugie, A. Rivenson, 1988, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Effects of fluorine substitution on the DNA binding and tumorigenicity of benzo[b]fluoranthene in mouse epidermis.

E. LaVoie, S. Amin, S. Hecht, 1989, Chemico-biological interactions.

Methylated derivatives of pyrene and fluorene: evaluation of genotoxicity in the hepatocyte/DNA repair test and tumorigenic activity in newborn mice.

E. LaVoie, J. E. Rice, A. Rivenson, 1987, Journal of toxicology and environmental health.

On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats.

E. LaVoie, J. Adams, D. Hoffmann, 1985, Carcinogenesis.

The role of acetylation in the mutagenicity of the antitumor agent, batracylin.

E. LaVoie, C. Mcqueen, G. Stevens, 1996, Carcinogenesis.

A G-quadruplex Stabilizer Induces M-phase Cell Cycle Arrest*

E. LaVoie, J. E. Rice, Chao-Po Lin, 2009, The Journal of Biological Chemistry.

Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds.

E. LaVoie, J. E. Rice, D. S. Pilch, 2008, Biochimie.

Tumour initiating activity of dihydrodiols of benzo[b]fluoranthene, benzo[j]fluoranthene, and benzo[k]fluoranthene.

E. LaVoie, S. Amin, S. Hecht, 1982, Carcinogenesis.

Comments on the toxicity of constituents in clove cigarette smoke

John D. Adams, E. LaVoie, D. Hoffmann, 1986, Archives of Toxicology.

Macrocyclic hexaoxazoles: Influence of aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity.

E. LaVoie, J. E. Rice, D. S. Pilch, 2010, Bioorganic & medicinal chemistry letters.

Novel MreB inhibitors with antibacterial activity against Gram (-) bacteria

E. LaVoie, D. S. Pilch, Yanlu Cao, 2022, Medicinal Chemistry Research.

Analyses of steam distillates and aqueous extracts of smokeless tobacco

John D. Adams, E. LaVoie, D. Hoffmann, 1989 .

The carcinogenicity of quinoline and benzoquinolines in newborn CD-1 mice.

E. LaVoie, A. Rivenson, A. Shigematsu, 1987, Japanese journal of cancer research : Gann.

Identification of mutagenic dihydrodiols as metabolites of benzo(j)fluoranthene and benzo(k)fluoranthene.

E. LaVoie, S. Amin, S. Hecht, 1980, Cancer research.

5-Methylchrysene metabolism in mouse epidermis in vivo, diol epoxide--DNA adduct persistence, and diol epoxide reactivity with DNA as potential factors influencing the predominance of 5-methylchrysene-1,2-diol-3,4-epoxide--DNA adducts in mouse epidermis.

E. LaVoie, S. Hecht, D. Hoffmann, 1983, Carcinogenesis.

Bioassay of quinoline, 5-fluoroquinoline, carbazole, 9-methylcarbazole and 9-ethylcarbazole in newborn mice.

S. Meegalla, E. LaVoie, C. Mcqueen, 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Relative tumor initiating activity of benzo[a]fluoranthene, benzo[b]fluoranthene, naphtho[1,2-b]fluoranthene and naphtho[2,1-a]fluoranthene on mouse skin.

E. LaVoie, R. Harvey, E. Weyand, 1990, Cancer letters.

Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.

E. LaVoie, S. Hecht, D. Hoffmann, 1982, Cancer research.

Identification of metabolites of benzo[b]fluoranthene.

E. LaVoie, S. Amin, S. Hecht, 1982, Carcinogenesis.

Metabolic activation of methylated phenanthrenes

E. LaVoie, D. Hoffman, L. T. Freiler, 1981 .

Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene.

E. LaVoie, S. Hecht, E. Boger, 1981, Cancer research.

Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment

B. Teicher, E. LaVoie, M. Yao, 2011, Clinical Cancer Research.

Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors

B. Teicher, E. LaVoie, M. Yao, 2008, Molecular Cancer Therapeutics.

Syntheses and biological evaluation of topoisomerase I-targeting agents related to 11-[2-(N,N-dimethylamino)ethyl]-2,3-dimethoxy-8,9-methylenedioxy-11H-isoquino[4,3-c]cinnolin-12-one (ARC-31).

E. LaVoie, Leroy F. Liu, Y. Tsai, 2008, Bioorganic & medicinal chemistry.

Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2004, Bioorganic & medicinal chemistry letters.

Pharmacokinetics of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals.

E. LaVoie, J. Adams, D. Hoffmann, 1985, Cancer letters.

Antibacterial activity of substituted 5-methylbenzo[c]phenanthridinium derivatives.

E. LaVoie, D. S. Pilch, M. Kaul, 2012, Bioorganic & medicinal chemistry letters.

Nitroarylstannanes as synthons for the preparation of phenanthridine and benzo[i]phenanthridine derivatives.

E. LaVoie, B. Zhao, D. Li, 2000, The Journal of organic chemistry.

5H-Dibenzo[c,h]1,6-naphthyridin-6-ones: novel topoisomerase I-targeting anticancer agents with potent cytotoxic activity.

A. Ray, E. LaVoie, Jin-Ming Yang, 2003, Bioorganic & medicinal chemistry.

Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.

Peter J Houghton, Parima Daroui, P. Houghton, 2003, Cancer research.

Nitro and amino substitution in the D-ring of 5-(2-dimethylaminoethyl)- 2,3-methylenedioxy-5H-dibenzo[c,h][1,6]naphthyridin-6-ones: effect on topoisomerase-I targeting activity and cytotoxicity.

E. LaVoie, Alexander L. Ruchelman, Leroy F. Liu, 2003, Journal of medicinal chemistry.

Aza-analogs of dibenzo[c,h]cinnoline: Triazachrysenes as potent topoisomerase I-targeting anticancer agents

E. LaVoie, Alexander L. Ruchelman, N. Zhou, 2003 .

Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agents.

E. LaVoie, Leroy F. Liu, Tsai-Kun Li, 2003, Bioorganic & medicinal chemistry.

Antineoplastic activity of benzimidazo[1,2-b]-isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles.

C. Yu, E. LaVoie, L. Barrows, 1994, Bioorganic & medicinal chemistry.

11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.

A. Ray, E. LaVoie, Jin-Ming Yang, 2004, Bioorganic & medicinal chemistry.

Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons.

Q. Sun, C. Yu, A. Liu, 1996, Bioorganic & medicinal chemistry.

A terbenzimidazole that preferentially binds and conformationally alters structurally distinct DNA duplex domains: a potential mechanism for topoisomerase I poisoning.

Z. Xu, Q. Sun, E. LaVoie, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.

B. Gatto, C. Yu, A. Liu, 1996, Journal of medicinal chemistry.

Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agents.

E. LaVoie, J. E. Rice, D. S. Pilch, 2010, Journal of medicinal chemistry.

TUMOR INHIBITORS. 120. PHYLLANTHOCIN, A NOVEL BISABOLANE AGLYCONE FROM THE ANTILEUKEMIC GLYCOSIDE, PHYLLANTHOSIDE

E. LaVoie, S. M. Kupchan, R. Bryan, 1977 .

Phyllanthocin, a novel bisabolane aglycone from the antileukemic glycoside, phyllanthoside.

E. LaVoie, S. M. Kupchan, R. Bryan, 1977, Journal of the American Chemical Society.

5-(2-aminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: variation of n-alkyl substituents modulates sensitivity to efflux transporters associated with multidrug resistance.

Nai Zhou, Peter J Houghton, P. Houghton, 2005, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of isoindolo[1,2-b]quinazolinone and isoindolo[2,1-a]benzimidazole derivatives related to the antitumor agent batracylin.

S. Meegalla, C. Yu, L. Liu, 1994, Journal of medicinal chemistry.

Synthesis of fluorinated derivatives of benzo[k]fluoranthene and indeno[1,2,3-cd]pyrene and 8,9-dihydro-8,9-epoxybenzo[k]fluoranthene

E. LaVoie, J. E. Rice, A. Czech, 1988 .

Antioxidative Phenolic Compounds from Sage (Salvia officinalis)

E. LaVoie, Mingfu Wang, Chi-Tang Ho, 1998 .

Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation.

L. Liu, E. LaVoie, N. Zhou, 2001, Biochemistry.

Diaza- and triazachrysenes: potent topoisomerase-targeting agents with exceptional antitumor activity against the human tumor xenograft, MDA-MB-435.

A. Ray, E. LaVoie, Jin-Ming Yang, 2002, Bioorganic & medicinal chemistry letters.

Synthesis of benzimidazo[2,1-a]isoquinolines and 5,6-dihydrobenzimidazo[2,1-a]isoquinolines

E. LaVoie, Qun Sun, 1996 .

Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, Shejin Zhu, Alexander L. Ruchelman, 2004, Bioorganic & medicinal chemistry letters.

Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity.

E. LaVoie, J. Kerrigan, Alexander L. Ruchelman, 2004, Bioorganic & medicinal chemistry.

5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]naphthyridin-6-ones and related compounds as TOP1-targeting agents: influence of structure on the ternary cleavable complex formation.

E. LaVoie, D. S. Pilch, J. Kerrigan, 2003, Bioorganic & medicinal chemistry letters.

Synthesis of 2-methylbenzo[b]furans and 2-methylbenzo[b]thiophens

E. LaVoie, W. Anderson, 1974 .

Use of 2,3-dichloropropene and 1,3-dichlorobut-2-ene as synthons for heterocyclic compounds: synthesis of 2-methylbenzo[b]furans, 2-methylbenzo[b]thiophens, and 4-methyl-2H-chromen

E. LaVoie, J. Bottaro, W. Anderson, 1976 .

2,3-Dimethoxybenzo[i]phenanthridines: topoisomerase I-targeting anticancer agents.

E. LaVoie, Leroy F. Liu, Tsai-Kun Li, 2003, Bioorganic & medicinal chemistry.

Synthesis of anti- and syn- diol epoxides of trans-4,5-dihydro-4,5-dihydroxybenzo[j]fluoranthene and trans-9,10-dihydro-9,10-dihydroxybenzo[j]fluoranthene

E. LaVoie, J. E. Rice, Zhenjie He, 1992 .

Short-term studies on the in vivo metabolism of N-oxides of nicotine in rats.

E. LaVoie, N. Haley, D. Sepkovic, 1986, Journal of toxicology and environmental health.

Structural Flexibility of an Inhibitor Overcomes Drug Resistance Mutations in Staphylococcus aureus FtsZ.

E. LaVoie, D. S. Pilch, E. Mizohata, 2017, ACS chemical biology.

Lysinyl macrocyclic hexaoxazoles: synthesis and selective G-quadruplex stabilizing properties.

E. LaVoie, J. E. Rice, D. S. Pilch, 2008, Bioorganic & medicinal chemistry letters.

Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocycles.

E. LaVoie, J. E. Rice, D. S. Pilch, 2006, Bioorganic & medicinal chemistry letters.

Ring-closing metathesis for the synthesis of a highly G-quadruplex selective macrocyclic hexaoxazole having enhanced cytotoxic potency.

E. LaVoie, J. E. Rice, D. S. Pilch, 2008, Bioorganic & medicinal chemistry letters.

Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA

A. R. Srinivasan, E. LaVoie, J. E. Rice, 2007, Nucleic acids research.

Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions.

A. R. Srinivasan, W. Olson, L. Liu, 2000, Biochemistry.

Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs.

A. R. Srinivasan, W. Olson, C. Yu, 1997, Biochemistry.

Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.

B. Gatto, C. Yu, L. Liu, 1996, Cancer research.

C. Yu, A. Liu, L. Liu, 1996, Bioorganic & medicinal chemistry.

Novel topoisomerase I-targeting antitumor agents synthesized from the N,N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N,N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2008, European journal of medicinal chemistry.

Antioxidative phenolic glycosides from sage (Salvia officinalis).

J Li, E. LaVoie, C. Ho, 1999, Journal of natural products.

Combination with a FtsZ inhibitor potentiates the in vivo efficacy of oxacillin against methicillin-resistant Staphylococcus aureus

E. LaVoie, D. S. Pilch, M. Kaul, 2022, Medicinal Chemistry Research.

Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli.

E. LaVoie, D. S. Pilch, M. Kaul, 2019, European journal of medicinal chemistry.

Advances in the structural studies of antibiotic potentiators against Escherichia coli.

E. LaVoie, D. S. Pilch, M. Kaul, 2019, Bioorganic & medicinal chemistry.

The influence of methyl substitution of the mutagenicity of nitronaphthalenes and nitrobiphenyls.

E. LaVoie, S. Hecht, D. Hoffmann, 1981, Mutation research.

Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.

E. LaVoie, Leroy F. Liu, Tsai-Kun Li, 2003, Bioorganic & medicinal chemistry.

Substituted benz[a]acridines and benz[c]acridines as mammalian topoisomerase poisons.

C. Yu, A. Liu, L. Liu, 2000, Bioorganic & medicinal chemistry.

Nicotine: a precursor for carcinogens.

E. LaVoie, S. Hecht, D. Hoffmann, 1985, Cancer letters.

Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.

E. LaVoie, D. Hoffmann, A. Rivenson, 1985, Journal of the National Cancer Institute.

Skin bioassays in tobacco carcinogenesis.

E. Wynder, E. LaVoie, S. Hecht, 1983, Progress in experimental tumor research.

Mutagenic activity of the 4,5‐ and 9,10‐dihydrodiols of benzo[J]fluoranthene and their syn‐ and anti‐dihydrodiol epoxides in salmonella typhimurium

E. LaVoie, J. E. Rice, Zhenjie He, 1993, Environmental and molecular mutagenesis.

1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene.

E. LaVoie, S. Hecht, D. Hoffmann, 1978, Cancer research.

The influence of fluoranthene on the metabolism and DNA binding of benzo[a]pyrene in vivo in mouse skin.

E. LaVoie, J. E. Rice, C. Sensenhauser, 1988, Chemico-biological interactions.

Tuimorigenic activity of fluoranthene, 2-methylfluoranthene and 3-methylfluoranthene in newborn CD-I mice

E. LaVoie, Z. Cai, E. Weyand, 1994 .

Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters

E. LaVoie, D. Hoffmann, A. Rivenson, 1986, Archives of Toxicology.

SYNTHESIS OF 6,9-BISNORMETHYL-8-METHOXY-12,13-EPOXY-6,8,10-TRICHOTHECATRIENE

George E. Lee, E. LaVoie, W. Anderson, 1977 .

Metabolism and mutagenic activity of benzo[k]fluoranthene and 3-, 8- and 9-fluorobenzo[k]fluoranthene.

E. LaVoie, J. E. Rice, S. Amin, 1988, Carcinogenesis.

11,12-Epoxy-9,10,11,12-tetrahydro-5,9,10-trihydroxybenzo[b]fluoranthene: Its Role in the Metabolic Activation of B[b]F in Mouse Skin

E. LaVoie, J. E. Rice, Z. Cai, 1994 .

Evaluation of the tumor-initiating activity of 4-, 5-, 6-, and 7-fluorobenzo[b]fluoranthene in mouse skin.

E. LaVoie, Z. Cai, R. Meegalla, 1993, Chemico-biological interactions.

Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity.

E. LaVoie, E. Weyand, M. V. Marshall, 1992, Chemico-biological interactions.

Steric and electronic factors which effect the thermal cyclization of metasubstituted aryl propargyl ethers. Synthesis of 5- and 7-substituted 3-chromenes

E. LaVoie, P. G. Whitkop, W. Anderson, 1974 .

A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.

S. Tuske, E. Arnold, E. LaVoie, 2012, Journal of medicinal chemistry.

Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells.

A. Liu, L. Liu, E. LaVoie, 1998, Biochemical pharmacology.

Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

Steven F. Baker, E. Arnold, E. LaVoie, 2013, ACS chemical biology.

Synthesis of the isomeric phenols and the trans-2,3-dihydrodiol of fluoranthene

E. LaVoie, J. E. Rice, D. Hoffmann, 1983 .

Topoisomerase I inhibition and cytotoxicity of 5-bromo- and 5-phenylterbenzimidazoles.

A. Liu, L. Liu, E. LaVoie, 2000, Bioorganic & medicinal chemistry.

Effects of ortho-methyl substituents on the mutagenicity of aminobiphenyls and aminonaphthalenes.

E. LaVoie, S. Hecht, K. El-Bayoumy, 1981, Mutation research.

Protoberberine Alkaloid Coralyne Identification of Topoisomerase I as the Cytotoxic Target of the Updated

B. Gatto, E. LaVoie, M. Sanders, 2006 .

2"-Substituted 5-phenylterbenzimidazoles as topoisomerase I poisons.

A. Liu, L. Liu, E. LaVoie, 2000, Bioorganic & medicinal chemistry.

Structure activity of topoisomerase i poisons related to hoechst 33342

E. LaVoie, Qun Sun, Leroy F. Liu, 1994 .

12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2009, Bioorganic & medicinal chemistry.

Cytotoxicity and TOP1-targeting activity of 8- and 9-amino derivatives of 5-butyl- and 5-(2-N,N-dimethylamino)ethyl-5H-dibenzo[c,h][1,6]naphthyridin-6-ones.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2009, European journal of medicinal chemistry.

11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2008, Bioorganic & medicinal chemistry.

EFFECTS OF TOPOISOMERASES INHIBITORS PROTOBERBERINE ON LEISHMANIA DONOVANI GROWTH, MACROPHAGE FUNCTION, AND INFECTION

E. LaVoie, M. Olivier, J. Marquis, 2003, The Journal of parasitology.

Heterocyclic bibenzimidazole derivatives as topoisomerase I inhibitors.

A. Liu, L. Liu, E. LaVoie, 2000, Bioorganic & medicinal chemistry letters.

Quantitative structure-activity relationships on 5-substituted terbenzimidazoles as topoisomerase I poisons and antitumor agents.

Q. Sun, C. Yu, A. Liu, 1998, Bioorganic & medicinal chemistry.

Substituted 2,5′-Bi-1H-benzimidazoles: Topoisomerase I Inhibition and Cytotoxicity.

B. Gatto, E. LaVoie, Leroy F. Liu, 1996 .

Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2008, Bioorganic & medicinal chemistry letters.

Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents.

E. LaVoie, Leroy F. Liu, Y. Tsai, 2008, Bioorganic & medicinal chemistry.

Genotoxicity of fluoroquinolines and methylquinolines.

E. LaVoie, C. Mcqueen, B. M. Way, 1991, Carcinogenesis.

Tumor-initiating activity of quinoline and methylated quinolines on the skin of SENCAR mice.

E. LaVoie, D. Hoffmann, J. Rigotty, 1984, Cancer letters.

Quinoline and methylquinolines in cigarette smoke: comparative data and the effect of filtration.

E. LaVoie, J. Adams, D. Hoffmann, 1983, Journal of analytical toxicology.

Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus

E. LaVoie, D. S. Pilch, M. Kaul, 2016, Antimicrobial Agents and Chemotherapy.

Thyroid Hormone Concentrations in Rats after Chronic Nicotine Metabolite Administration

E. LaVoie, N. Haley, D. Sepkovic, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Mutagenicity of substituted phenanthrenes in Salmonella typhimurium.

E. LaVoie, D. Hoffmann, V. Bedenko, 1983, Mutation research.

Volatile nitrosamines: analysis in breast fluid and blood of non-lactating women.

E. LaVoie, D. Hoffmann, E. Wynder, 1981, Food and cosmetics toxicology.

Aryl and Arylalkyl Substituted 3‐Hydroxypyridin‐2(1H)‐ones: Synthesis and Evaluation as Inhibitors of Influenza A Endonuclease

E. Arnold, E. LaVoie, A. Nogales, 2019, ChemMedChem.

Mutagenicity of aminophenyl and nitrophenyl ethers, sulfides, and disulfides.

E. LaVoie, D. Hoffmann, L. Tulley, 1979, Mutation research.

Enterococcal and streptococcal resistance to PC190723 and related compounds: molecular insights from a FtsZ mutational analysis.

S. Tuske, E. Arnold, E. LaVoie, 2013, Biochimie.

Studies on the mutagenicity and tumor-initiating activity of methylated fluorenes.

E. LaVoie, J. E. Rice, N. Geddie, 1985, Chemico-biological interactions.

Mutagenicity of methylated fluorenes and benzofluorenes.

E. LaVoie, D. Hoffmann, L. Tulley, 1981, Mutation research.

PHARMACOKINETICSOFN'-NITROSONORNIC~TINEAND 4-(METHYLNITROSAMINO)-l-(3-PYRIDYL)-1-BUTANONEIN h LABORATORYANIMALS*

E. LaVoie, K. Carey, J. Kathleen, 1985 .

Tumorigenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-diol epoxides in newborn mice.

E. LaVoie, E. Weyand, C. Meschter, 1994, Cancer research.

Methylene-bridged bay region chrysene and phenanthrene derivatives and their keto-analogs: mutagenicity in Salmonella typhimurium and tumor-initiating activity on mouse skin.

E. LaVoie, J. E. Rice, G. Makowski, 1985, Cancer letters.

Mutagenicity of aminocarbazoles and nitrocarbazoles.

E. LaVoie, D. Hoffmann, G. Briggs, 1981, Mutation research.

TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens

J. Y. Roberge, E. LaVoie, D. S. Pilch, 2022, Antibiotics.

Detection of the major DNA adducts of benzo[b]fluoranthene in mouse skin: role of phenolic dihydrodiols.

E. LaVoie, J. E. Rice, Z. Cai, 1993, Chemical research in toxicology.

Detection of the major DNA adducts of benzo[j]fluoranthene in mouse skin: nonclassical dihydrodiol epoxides.

E. LaVoie, Zhenjie He, E. Weyand, 1993, Chemical research in toxicology.

Reductionof Tumorigenicityand of DihydrodiolFormation by Fluorine Substitutionin the Angular Ringsof Dibenzo(a,/)pyrene1

E. LaVoie, S. Hecht, E. Boger, 1981 .

On the metabolic activation of 5-methylchrysene

E. LaVoie, S. Hecht, D. Hoffmann, 1978 .

Tumor-initiating activity and metabolism of polymethylated phenanthrenes.

E. LaVoie, D. Hoffmann, V. Bedenko, 1982, Cancer research.

Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.

E. LaVoie, D. Hoffman, V. Bedenko, 1981, Cancer research.

Fluoranthene and pyrene enhance benzo[a]pyrene--DNA adduct formation in vivo in mouse skin.

E. LaVoie, J. E. Rice, T. Hosted, 1984, Cancer letters.

Identification of tumorigenic metabolites of benzo[j]fluoranthene formed in vivo in mouse skin.

E. LaVoie, J. E. Rice, E. Weyand, 1987, Cancer research.

Identification of mutagenic metabolites of indeno[1,2,3-cd]pyrene formed in vitro with rat liver enzymes.

E. LaVoie, J. E. Rice, J. Wiley, 1985, Cancer research.

Transfer of the tobacco-specific carcinogens N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene into the milk of lactating rats.

E. LaVoie, J. Adams, S. Stern, 1987, Carcinogenesis.

Identification of metabolites of benzo[j]fluoranthene formed in vitro in rat liver homogenate.

E. LaVoie, J. E. Rice, N. Geddie, 1987, Chemico-biological interactions.

Effect of snuff and nicotine on DNA methylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

E. LaVoie, J. Adams, D. Hoffmann, 1987, Carcinogenesis.

Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.

E. LaVoie, H. Sikka, S. K. Dubey, 1989, Cancer research.

Pharmacokinetics of tobacco-specific N-nitrosamines.

E. LaVoie, J. Adams, D. Hoffmann, 1984, IARC scientific publications.

On the metabolic activation of the environmental carcinogens benzo(j)fluoroanthene and benzo(b)fluoranthene

E. LaVoie, S. Hecht, V. Bedenko, 1979 .

Macrocyclic Pyridyl Polyoxazoles: Structure-Activity Studies of the Aminoalkyl Side-Chain on G-Quadruplex Stabilization and Cytotoxic Activity

E. LaVoie, J. E. Rice, D. S. Pilch, 2013, Molecules.

Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar.

B. Gatto, C. Yu, A. Liu, 1997, Biochemistry.

Mutagenicity of substituted carbazoles in Salmonella typhimurium.

E. LaVoie, D. Hoffmann, V. Bedenko, 1982, Mutation research.

Carcinogenicity in Syrian golden hamsters of N-nitrosamines formed during nitrosation of spermidine.

E. LaVoie, D. Hoffmann, A. Rivenson, 1981, Cancer detection and prevention.

Comparison of the steam-volatile components of commercial cigarette, pipe, and chewing tobaccos

E. LaVoie, D. Hoffmann, Patricia L. Tucciarone, 1985 .

Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant Staphylococcus aureus.

E. LaVoie, D. S. Pilch, M. Kaul, 2023, ACS Chemical Biology.

Structure-Guided Design of a Fluorescent Probe for the Visualization of FtsZ in Clinically Important Gram-Positive and Gram-Negative Bacterial Pathogens

E. LaVoie, D. S. Pilch, J. Boyd, 2019, Scientific Reports.

Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.

E. LaVoie, S. Amin, S. Hecht, 1979, Journal of Medicinal Chemistry.

Mutagens in human urine: effects of cigarette smoking and diet.

E. LaVoie, I. Sasson, D. Hoffmann, 1985, Mutation research.

Macrocyclic biphenyl tetraoxazoles: synthesis, evaluation as G-quadruplex stabilizers and cytotoxic activity.

E. LaVoie, J. E. Rice, D. S. Pilch, 2013, Bioorganic & medicinal chemistry.

β-Lactam Antibiotics with a High Affinity for PBP2 Act Synergistically with the FtsZ-Targeting Agent TXA707 against Methicillin-Resistant Staphylococcus aureus

E. LaVoie, D. S. Pilch, M. Kaul, 2017, Antimicrobial Agents and Chemotherapy.

Abstract C76: Oxazole‐containing macrocyles as selective G‐quadruplex stabilizers

E. LaVoie, J. E. Rice, D. S. Pilch, 2009 .

Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment

B. Teicher, E. LaVoie, M. Yao, 2011, Clinical Cancer Research.